Buscar resultados de ensayos clínicos
Ascites - 164 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites Condición: Refractory Malignant Ascites Fecha: 2013-05-08 Intervenciones: Drug: bevacizumab Other Name: Avastin |
Completed |
Nombre del estudio: A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal Condición: Refractory Ascites Fecha: 2009-03-25 Intervenciones: Device: AFS System AFS System with patient specific flow rate |
Terminated |
Nombre del estudio: Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites Condición: Malignant Ascites Fecha: 2015-07-01 Intervenciones: Drug: Intraperitoneal Bevacizumab Bevacizumab 200mg diluted in 250 ml of normal saline |
Completed |
Nombre del estudio: Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia Condición: Cirrhotic Ascites Fecha: 2010-08-10 Intervenciones:
|
Completed |
Nombre del estudio: Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial. Condición: Massive Ascites Fecha: 2016-08-11 Intervenciones:
|
Completed |
Nombre del estudio: Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites Condición: Refractory Malignant Ascites Fecha: 2016-09-01 Intervenciones: Other: No intervention. Descriptive study |
Completed |
Nombre del estudio: Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites Condición:
Fecha: 2007-07-13 Intervenciones: Drug: satavaptan (SR121463B) |
Completed |
Nombre del estudio: Satavaptan Dose-Ranging Study in the Prevention of Ascites Condición:
Fecha: 2007-07-13 Intervenciones: Drug: satavaptan (SR121463B) |
Completed |
Nombre del estudio: ALFApump System Versus Standard of Care in Ascites Treatment Condición: Refractory or Recurrent Ascites Fecha: 2012-01-31 Intervenciones:
|
Completed |
Nombre del estudio: Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites Condición: Malignant Ascites Due to Epithelial Carcinoma Fecha: 2010-01-13 Intervenciones: Drug: catumaxomab 4 intraperitoneal infusions within 11 days administered over 3 hours via an indwelling |